1,193,858 research outputs found

    Loss of control testing of light aircraft and a cost effective approach to flight test

    Get PDF
    Copyright @ The Society of Flight Test EngineersLoss of control in Visual Meteorological Conditions (VMC) is the most common cause of fatal accidents involving light aircraft in the UK and probably worldwide. Understanding why LoC events occur and why there are apparent differences between aircraft types is currently under investigation by Brunel Flight Safety Laboratory (BFSL). Using a case study approach for selected light aircraft used in the training environment and based upon a 29 year study of UK fatal accidents, BFSL undertook a qualitative and quantitative review of fatal stall/spin accidents using a combination of statistical and qualitative analysis. Aircraft/model design differences and published material were reviewed with respect to performance and handling qualities for possible clues, and informal interviews were conducted with type-experienced students, pilots and flying instructors. A flight test programme was executed using multiple examples (for fleet-wide attributes) of aircraft models to enable assessment and comparison of flying qualities (both qualitatively and quantitatively). Working within the continuous budget constraints of academia, a creative and cost effective flight test programme was developed without compromising safety. The two-man team (TP & FTE) used standard (unmodified) flying club and syndicate aircraft in conjunction with non-invasive low cost flight test instrumentation. Tests included apparent longitudinal (static and dynamic) stability and control characteristics, stall and low-speed handling characteristics and cockpit ergonomics / pilot workload. During this programme, adaptations were also made to the classic Cooper-Harper “point tracking” method towards a “boundary avoidance” method. The paper describes tools and techniques used, research findings, the team's lessons learned and proposed future research. It also discusses the possible application of research results in aircraft, pilot and environmental causal factors, enabling a better understanding of LoC incidents and future avoidance within the light aircraft community.Financial support from the Thomas Gerald Gray Charitable Trust Research Scholarship Scheme was used in this study

    Test-Signal Search for Mixed-Signal Cores in a System-on-Chip

    Get PDF
    The well-known approach towards testing mixed-signal cores is functional testing and basically measuring key parameters of the core. However, especially if performance requirements increase, and embedded cores are considered, functional testing becomes technically and economically less attractive. A more cost-effective approach could be accomplished by a combination of reduced functional tests and added structural tests. In addition, it will also improve the debugging facilities of cores. Basic problem remains the large computational effort for analogue structural testing. In this paper, we introduce the concept of Testability Transfer Function for both analogue as well as digital parts in a mixed-signal core. This opens new possibilities for efficient structural testing of embedded mixed-signal cores, thereby adding to\ud the quality of tests

    HYBRID DATA APPROACH FOR SELECTING EFFECTIVE TEST CASES DURING THE REGRESSION TESTING

    Get PDF
    In the software industry, software testing becomes more important in the entire software development life cycle. Software testing is one of the fundamental components of software quality assurances. Software Testing Life Cycle (STLC)is a process involved in testing the complete software, which includes Regression Testing, Unit Testing, Smoke Testing, Integration Testing, Interface Testing, System Testing & etc. In the STLC of Regression testing, test case selection is one of the most important concerns for effective testing as well as cost of the testing process. During the Regression testing, executing all the test cases from existing test suite is not possible because that takes more time to test the modified software. This paper proposes new Hybrid approach that consists of modified Greedy approach for handling the test case selection and Genetic Algorithm uses effective parameter like Initial Population, Fitness Value, Test Case Combination, Test Case Crossover and Test Case Mutation for optimizing the tied test suite. By doing this, effective test cases are selected and minimized the tied test suite to reduce the cost of the testing process. Finally the result of proposed approach compared with conventional greedy approach and proved that our approach is more effective than other existing approach

    Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation

    Get PDF
    BACKGROUND: Liver biopsy is the reference standard for diagnosing the extent of fibrosis in chronic liver disease; however, it is invasive, with the potential for serious complications. Alternatives to biopsy include non-invasive liver tests (NILTs); however, the cost-effectiveness of these needs to be established. OBJECTIVE: To assess the diagnostic accuracy and cost-effectiveness of NILTs in patients with chronic liver disease. DATA SOURCES: We searched various databases from 1998 to April 2012, recent conference proceedings and reference lists. METHODS: We included studies that assessed the diagnostic accuracy of NILTs using liver biopsy as the reference standard. Diagnostic studies were assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. Meta-analysis was conducted using the bivariate random-effects model with correlation between sensitivity and specificity (whenever possible). Decision models were used to evaluate the cost-effectiveness of the NILTs. Expected costs were estimated using a NHS perspective and health outcomes were measured as quality-adjusted life-years (QALYs). Markov models were developed to estimate long-term costs and QALYs following testing, and antiviral treatment where indicated, for chronic hepatitis B (HBV) and chronic hepatitis C (HCV). NILTs were compared with each other, sequential testing strategies, biopsy and strategies including no testing. For alcoholic liver disease (ALD), we assessed the cost-effectiveness of NILTs in the context of potentially increasing abstinence from alcohol. Owing to a lack of data and treatments specifically for fibrosis in patients with non-alcoholic fatty liver disease (NAFLD), the analysis was limited to an incremental cost per correct diagnosis. An analysis of NILTs to identify patients with cirrhosis for increased monitoring was also conducted. RESULTS: Given a cost-effectiveness threshold of £20,000 per QALY, treating everyone with HCV without prior testing was cost-effective with an incremental cost-effectiveness ratio (ICER) of £9204. This was robust in most sensitivity analyses but sensitive to the extent of treatment benefit for patients with mild fibrosis. For HBV [hepatitis B e antigen (HBeAg)-negative)] this strategy had an ICER of £28,137, which was cost-effective only if the upper bound of the standard UK cost-effectiveness threshold range (£30,000) is acceptable. For HBeAg-positive disease, two NILTs applied sequentially (hyaluronic acid and magnetic resonance elastography) were cost-effective at a £20,000 threshold (ICER: £19,612); however, the results were highly uncertain, with several test strategies having similar expected outcomes and costs. For patients with ALD, liver biopsy was the cost-effective strategy, with an ICER of £822. LIMITATIONS: A substantial number of tests had only one study from which diagnostic accuracy was derived; therefore, there is a high risk of bias. Most NILTs did not have validated cut-offs for diagnosis of specific fibrosis stages. The findings of the ALD model were dependent on assuptions about abstinence rates assumptions and the modelling approach for NAFLD was hindered by the lack of evidence on clinically effective treatments. CONCLUSIONS: Treating everyone without NILTs is cost-effective for patients with HCV, but only for HBeAg-negative if the higher cost-effectiveness threshold is appropriate. For HBeAg-positive, two NILTs applied sequentially were cost-effective but highly uncertain. Further evidence for treatment effectiveness is required for ALD and NAFLD. STUDY REGISTRATION: This study is registered as PROSPERO CRD42011001561. FUNDING: The National Institute for Health Research Health Technology Assessment programme

    Cost-effectiveness of the Manchester approach to identifying Lynch syndrome in women with endometrial cancer

    Get PDF
    This is the final version. Available on open access from MDPI via the DOI in this recordLynch syndrome (LS) is a hereditary cancer syndrome responsible for 3% of all endometrial cancer and 5% in those aged under 70 years. It is unclear whether universal testing for LS in endometrial cancer patients would be cost-effective. The Manchester approach to identifying LS in endometrial cancer patients uses immunohistochemistry (IHC) to detect mismatch repair (MMR) deficiency, incorporates testing for MLH1 promoter hypermethylation, and genetic testing for pathogenic MMR variants. We aimed to assess the cost-effectiveness of the Manchester approach based on primary research data from clinical practice in Manchester. The PETALS study informed estimates of diagnostic performances for a number of different strategies. A recent microcosting study was adapted and used to estimate diagnostic costs. A Markov model was used to predict long-term costs and health outcomes (measured in quality-adjusted life years, QALYs) for individuals and their relatives. Bootstrapping and probabilistic sensitivity analysis were used to estimate the uncertainty in cost-effectiveness. The Manchester approach dominated other reflex testing strategies when considering diagnostic costs and Lynch syndrome cases identified. When considering long-term costs and QALYs the Manchester approach was the optimal strategy, costing £5459 per QALY gained (compared to thresholds of £20,000 to £30,000 per QALY commonly used in the NHS). Cost-effectiveness is not an argument for restricting testing to younger patients or those with a strong family history. Universal testing for Lynch syndrome in endometrial cancer patients is expected to be cost-effective in the UK NHS, and the Manchester approach is expected to be the optimal testing strategy.Medical Research Council (MRC)National Institute for Health Research (NIHR

    Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy.

    Get PDF
    Patients hospitalised because of mental illness often have risk factors for contracting HCV. Scaling-up HCV screening for all psychiatric inpatients as a case-detection strategy for viral elimination is underexplored. This study aimed to evaluate the cost-effectiveness of scaling-up HCV screening and treatment for psychiatry hospital admissions in Switzerland vs. the current standard-of-care risk-based approach, where only those with a history of substance misuse disorder are offered testing. HCV prevalence by history of substance misuse disorder was analysed in medical records from inpatient admissions to a Swiss psychiatry department. Cost-effectiveness was analysed from a healthcare provider perspective through a decision-tree screening model, using these HCV prevalence data. Model and parameter uncertainty were assessed using deterministic and probabilistic sensitivity analyses. Prevalence of HCV in psychiatry inpatients with a history of substance misuse disorder (n = 1,013) was 25.7%, compared with 3.5% among the remaining inpatients (n = 3,535). Scaling up HCV screening and treatment for all psychiatry admissions was cost-effective vs. the risk-based approach, with an incremental cost-effectiveness ratio of US9,188perqualityadjustedlifeyeargained.TheincrementalcosteffectivenessratioremainedcosteffectiveconsideringaHCVprevalenceaslowas0.079,188 per quality-adjusted life-year gained. The incremental cost-effectiveness ratio remained cost-effective considering a HCV prevalence as low as 0.07%. The population-level net monetary benefit of the generalised screening approach was US435,156,348, with 917 additional patients per year detected and treated at a cost of US3,294perperson(vs.US3,294 per person (vs. US2,122 under risk-based screening). Scaling up HCV screening and treatment at diagnosis with all-oral, interferon-free regimens as a generalised approach for psychiatric admissions was cost-effective and could support reaching World Health Organization targets for HCV elimination by 2030. Patients hospitalised because of mental illness often have risk factors for HCV. We found that testing all psychiatry patients in hospital for HCV was cost-effective compared with testing only patients who have a history of substance misuse. Scaling up HCV testing and treatment could help to wipe out HCV

    A Survey on Software Testing Techniques using Genetic Algorithm

    Full text link
    The overall aim of the software industry is to ensure delivery of high quality software to the end user. To ensure high quality software, it is required to test software. Testing ensures that software meets user specifications and requirements. However, the field of software testing has a number of underlying issues like effective generation of test cases, prioritisation of test cases etc which need to be tackled. These issues demand on effort, time and cost of the testing. Different techniques and methodologies have been proposed for taking care of these issues. Use of evolutionary algorithms for automatic test generation has been an area of interest for many researchers. Genetic Algorithm (GA) is one such form of evolutionary algorithms. In this research paper, we present a survey of GA approach for addressing the various issues encountered during software testing.Comment: 13 Page

    Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC.

    Get PDF
    BACKGROUND: Routine HIV testing is an essential approach to identifying undiagnosed infections, linking people to care and treatment, and preventing new infections. In Washington, DC, where HIV prevalence is 2.4%, a combination of routine and targeted testing approaches has been implemented since 2006. METHODS: We sought to evaluate the cost effectiveness of the District of Columbia (DC) Department of Health\u27s routine and targeted HIV testing implementation strategies. We collected HIV testing data from 3 types of DC Department of Health-funded testing sites (clinics, hospitals, and community-based organizations); collected testing and labor costs; and calculated effectiveness measures including cost per new diagnosis and cost per averted transmission. RESULTS: Compared to routine testing, targeted testing resulted in higher positivity rates (1.33% vs. 0.44%). Routine testing averted 34.30 transmissions per year compared to targeted testing at 17.78. The cost per new diagnosis was lower for targeted testing (2,467vs.2,467 vs. 7,753 per new diagnosis) as was the cost per transmission averted (33,160vs.33,160 vs. 104,205). When stratified by testing site, both testing approaches were most cost effective in averting new transmissions when conducted by community based organizations (25,037routine;25,037 routine; 33,123 targeted) compared to hospitals or clinics. CONCLUSIONS: While routine testing identified more newly diagnosed infections and averted more infections than targeted testing, targeted testing is more cost effective per diagnosis and per transmission averted overall. Given the high HIV prevalence in DC, the DC Department of Health\u27s implementation strategy should continue to encourage routine testing implementation with emphasis on a combined testing strategy among community-based organizations

    Operational modal analysis of a spar-type floating platform using frequency domain decomposition method

    Get PDF
    System identification of offshore floating platforms is usually performed by testing small-scale models in wave tanks, where controlled conditions, such as still water for free decay tests, regular and irregular wave loading can be represented. However, this approach may result in constraints on model dimensions, testing time, and costs of the experimental activity. For such reasons, intermediate-scale field modelling of offshore floating structures may become an interesting as well as cost-effective alternative in a near future. Clearly, since the open sea is not a controlled environment, traditional system identification may become challenging and less precise. In this paper, a new approach based on Frequency Domain Decomposition (FDD) method for Operational Modal Analysis is proposed and validated against numerical simulations in ANSYS AQWA v.16.0 on a simple spar-type structure. The results obtained match well with numerical predictions, showing that this new approach, opportunely coupled with more traditional wave tanks techniques, proves to be very promising to perform field-site identification of the model structures

    HIV Drug Resistance Among Infants and Children in South Africa: How Efficient is Genotypic Testing?

    Get PDF
    Background: South Africa has the largest prevalence of HIV infection. This epidemic impacts adults as well as the pediatric population. The presence of drug-resistant mutations to antiretroviral therapies among infants and children is on the rise. Few studies have been conducted on this topic. Objective: The study aims to determine whether drug resistance testing in the form of genotypic testing is cost-effective when deciding whether to switch to a new HIV antiretroviral therapy following drug failure. Method: An interactive research approach is taken by collecting primary data from experts in this field. Secondary sources including guidelines from the World Health Organization and the South African Department of Health were also analyzed. Results: This study finds that, at the moment, genotypic testing is not cost-effective and should not be employed in routine primary care clinics. Conclusion: Although not recommended for routine care, genotypic testing is extremely beneficial when determining the underlining cause of drug resistance and when tailoring individual regimens for patients. A scale-up of the HIV response and a low-cost drug resistance test are needed in order to make it cost-effective
    corecore